Logo: to the web site of Uppsala University
uu.se
Publications from Uppsala University
Please wait ...
Simple search
Advanced search -
Research publications
Advanced search -
Student theses
Statistics
English
Svenska
Norsk
Change search
Search
Export
JSON SweCris
Link to record
Permanent link
Direct link
http://uu.diva-portal.org/smash/project.jsf?pid=project:3637
BETA
Project
Project type/Form of grant
Project grant
Title [sv]
Funktionell och inflammatorisk mag-tarmsjukdom: Peptiderga regulatoriska mekanismer för behandling och metabol kontroll.
Title [en]
Functional and inflammatory gastrointestinal disorders: Peptidergic regulatory mechanisms for treatment and metabolic control.
Abstract [sv]
Functional diseases of the gastrointestinal (GI) tract are considered to affect motility and sensory mechanisms of the gut, with secondary effects on metabolic functions due to changes in nutrient absorption and hormonal release. In search of valid biomarkers we have found NO generation to be a hallmark of inflammatory conditions in the GI tract. This is separated from functional disorders where NO production is low. In the functional gut there is peptidergic regulatory predominance, which has been unravelled to disclose mechanisms for physiological regulation and pharmacological control in functional disorders. Techniques used involve NO detection by chemiluminescence, peptide analysis by Luminex immunoassay, RT-PCR and real-time PCR for detection and expression of receptors. Functional studies are done in organ baths, myoelectric recordings, gastric emptying and transit studies in rat; and organ bath, gastric emptying, and gut motility in man. Endocrine effects are monitored by plasma glucose, insulin, glucagon, glucose-dependent insulinotropic peptide. The research issue is now focused on GI peptide hormones with selective and prominent effects in functional disorders with a sensory component. Primarily glucagon-like peptide-1 (GLP-1) and analogues inhibit gut motility and tone which relieves symptoms in IBS and functional dyspepsia, while ghrelin and analogues stimulate motility in gastroparesis and enteric dysmotility, with increased levels in inflammatory gut disorders.
Principal Investigator
Hellström, Per
Uppsala University
Coordinating organisation
Uppsala University
Funder
Vetenskapsrådet
Period
2010-01-01 - 2012-12-31
Identifiers
DiVA, id: project:3637
Project, id: 2009-05293_VR
Search in DiVA
Search outside of DiVA
Google
Google Scholar
v. 2.50.0
|
WCAG
|
Uppsala University Library
|
Ask the Library
|
Log in to DiVA
|
Search and link in DiVA
DiVA
Logotyp